Collegium Pharmaceutical (COLL) vs Faeth Therapeutics (FTH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Faeth Therapeutics (FTH) has outperformed Collegium Pharmaceutical (COLL) over the past year, gaining 121.4% versus a loss of 34.3%. Over five years, COLL leads with a +4.5% price change compared with -83.7% for FTH. Collegium Pharmaceutical is the larger company by market cap ($713.9 million vs $643.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COLL | FTH |
|---|---|---|
| Share price | $21.93 | $24.92 |
| Market cap | $713.94M | $643.94M |
| 1-day change | +0.23% | -7.33% |
| YTD return | -52.63% | +133.55% |
| 1-year return | -34.32% | +121.39% |
| 5-year return | +4.53% | -83.67% |
| P/E ratio (TTM) | 17.27 | — |
| Forward P/E | 3.30 | — |
| EPS (TTM) | $1.27 | $-60.86 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $50.79 | $42.14 |
| 52-week low | $21.43 | $7.45 |
| Distance from 52-week high | -56.82% | -40.87% |
| Average volume | 743.01K | 348.41K |
| Shares outstanding | 32.56M | 25.84M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- FTH has outperformed COLL by 155.7 percentage points over the past year.
COLL vs FTH FAQ
Which is bigger, Collegium Pharmaceutical or Faeth Therapeutics?
Collegium Pharmaceutical (COLL) is larger, with a market capitalization of $713.94M compared with $643.94M for Faeth Therapeutics (FTH).
Which stock has performed better over the past year, COLL or FTH?
FTH returned +121.39% over the past 12 months, compared with -34.32% for COLL (price return, excluding dividends). Past performance does not predict future results.
Are Collegium Pharmaceutical and Faeth Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.